Seoul, South Korea

Hong Rhym


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Hong Rhym

Introduction

Hong Rhym is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of L-phenylalanine. With a total of two patents to his name, his work has implications for various industries, including pharmaceuticals and food production.

Latest Patents

Hong Rhym's latest patents include a method for the production of L-phenylalanine by an E. coli mutant. This novel E. coli strain is capable of producing L-phenylalanine while being resistant to high osmotic pressure. Additionally, he has developed a process for producing L-phenylalanine using this novel E. coli strain, designated as KCCM 10,016. His second patent involves a method for producing L-phenylalanine by recombinant E. coli, which can yield high amounts of the amino acid. This strain, KCCM 10,013, is transformed with a novel plasmid pMW16 that contains two promoters and a temperature-sensitive repressor for expressing the pheA gene and the aroF gene.

Career Highlights

Hong Rhym is associated with Miwon Co., Ltd., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in enhancing the efficiency of L-phenylalanine production.

Collaborations

Some of his notable coworkers include Byung L Lim and Hwa Young Kim, who have collaborated with him on various projects related to his patents.

Conclusion

Hong Rhym's contributions to the field of biotechnology, particularly in the production of L-phenylalanine, highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to developing efficient methods that can benefit multiple industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…